Skip to main content
Journal of Healthcare, Science and the Humanities logoLink to Journal of Healthcare, Science and the Humanities
. 2025 Spring;15(1):64–73.

Empathy in Action: Black Bioethics and the Role of Care Ethics in HPV Prevention and Education in Underserved Communities

David Augustin Hodge 1, John Heath 2, Ehsan A Ehsan Abdalla 3
PMCID: PMC13101409  PMID: 42027221

Abstract

This white paper explores the integration of Black bioethics and care ethics to address disparities in HPV and cervical cancer prevention among HIV-positive individuals in Alabama’s Black Belt Counties. Leveraging a justice-based framework, the paper examines the systemic inequities shaping these disparities and outlines a culturally relevant, community-driven response. The project employs a mixed-methods evaluation strategy, integrating innovative tools such as the “Protect Me From HPV” app, alongside robust educational interventions tailored to the socio-cultural realities of underserved populations. Ethical principles—including informed consent, participant autonomy, and community empowerment—serve as the foundation of the initiative. By embedding empathy and care ethics into its design, the project seeks to rebuild trust, dismantle barriers, promote health equity and demonstrate a sincere trustworthiness. This initiative reframes HPV prevention as both a scientific challenge and a moral imperative, providing a scalable model for ethically grounded public health interventions in marginalized communities.

Keywords: Black bioethics, Empathy ethics, Care ethics, HPV prevention, Health disparities, HIV-positive individuals, Public health, Justice, Social Justice

Introduction

Health disparities rooted in systemic inequities continue to disproportionately affect marginalized communities, particularly in rural and socioeconomically challenged regions like Alabama’s Black Belt Counties (BBCs). Among the most pressing public health concerns in these communities are the dual epidemics of HIV and HPV, which intersect to create heightened risks of cervical and other HPV-related cancers. HIV-positive individuals, particularly women, face an increased susceptibility to persistent HPV infections and precancerous conditions due to compromised immune systems. Despite the availability of preventive measures, such as vaccines and routine screenings, systemic barriers—such as limited healthcare access, socioeconomic challenges, and historical medical mistrust—have hindered widespread adoption in these underserved populations.

Addressing these health inequities requires a multifaceted approach grounded in public health ethics, empathy, and care. This paper outlines a comprehensive effort to understand, mitigate, and prevent HPV-related health disparities among HIV-positive individuals in Alabama’s BBCs. The project is designed around three specific aims: understanding the role of geographic and socioeconomic factors in shaping health behaviors and outcomes, assessing the impact of comorbidities and antiretroviral therapy on HPV progression, and implementing and evaluating educational interventions tailored to the unique needs of this population.

Central to this initiative is the integration of Black bioethics, a social justice-focused framework that acknowledges the systemic inequities faced by Black communities and seeks to rectify them through culturally relevant, community-driven solutions. In addition, the project employs empathy and care ethics to ensure that the voices, experiences, and dignity of participants remain central to every stage of the research process. By embedding these ethical principles into the design and evaluation of the project, the initiative seeks to not only address immediate health disparities but also foster long-term trust and empowerment within the affected communities.

This paper presents a detailed exploration of the project’s interdisciplinary approach, focusing on the biological dimensions of HIV and HPV, the practical implementation of educational interventions, and the ethical considerations that underpin the initiative. Through this effort, we aim to advance both scientific understanding and public health practice, providing a model for ethically grounded research that prioritizes equity, empathy, and community empowerment.

HIV and Increased Vulnerability to HPV

The intersection of HIV and HPV creates a unique health challenge, particularly in immunocompromised individuals. HIV weakens the immune system by reducing CD4 counts, which increases susceptibility to HPV infections and accelerates the progression of HPV-related conditions. This interaction is especially significant in cervical cancer, where over 99.7% of cases are linked to high-risk HPV types. HIV-positive individuals not only face a higher risk of acquiring HPV but also experience more severe and persistent infections. The presence of multiple HPV strains in these individuals is common, contributing to an elevated risk of anal, vaginal, vulvar, and penile cancers. Studies indicate that individuals with HIV have up to a 29-fold increased risk of anal cancer and a six-fold increased risk of cervical cancer compared to the general population.

Antiretroviral therapy (ART) has shown promise in managing these risks by reducing viral load and promoting immune reconstitution. However, even among individuals with effectively managed HIV, the risk of HPV acquisition and progression remains elevated due to lingering immune system vulnerabilities. ART’s success in improving life expectancy has also extended the period during which individuals may develop HPV-related conditions, highlighting the need for integrated preventive care strategies. Incorporating HPV vaccination into routine HIV care, including PrEP and nPrEP for high-risk populations, is an innovative approach that can significantly reduce HPV transmission and related cancer rates.

Disparities in HIV and HPV Outcomes

Geographic, socioeconomic, and racial disparities in health outcomes significantly exacerbate the challenges of managing HIV and HPV in underserved regions like Alabama’s Black Belt Counties. African Americans are seven times more likely to be diagnosed with HIV than Whites, and they account for over 70% of new HIV cases in the state despite comprising only 26.5% of the population. Limited access to healthcare facilities, lack of education, and systemic economic disadvantages create barriers to receiving regular care and preventive interventions. Moreover, stigma surrounding both HIV and HPV often discourages individuals from seeking testing, treatment, or vaccination.

The geographic isolation of Black Belt Counties further compounds these disparities. Many residents lack access to specialty clinics or programs providing PrEP, nPrEP, or HPV vaccinations, perpetuating cycles of high transmission rates and poor health outcomes. Young adults, particularly those aged 20–29, are disproportionately affected, representing 40% of new HIV diagnoses while only comprising 13% of Alabama’s population. Addressing these inequities requires culturally tailored interventions that not only improve healthcare access but also dismantle stigma through community engagement and education.

Public Health Implications of Coinfections

The coexistence of HIV and HPV presents unique challenges for healthcare providers, particularly in underserved communities. Managing these comorbid conditions requires addressing not only the biological complexities but also the systemic barriers that hinder effective care. For example, individuals with HIV often struggle with limited access to cervical cancer screenings and HPV vaccinations, leaving them vulnerable to preventable conditions. Additionally, stigma and misinformation about HIV and sexual health contribute to lower rates of preventive behaviors, such as condom use or regular health check-ups.

Evidence-based strategies, such as integrating HPV vaccination into HIV preventive care programs, show great promise in mitigating these challenges. Education campaigns targeting high-risk populations can significantly improve awareness and uptake of interventions like PrEP, nPrEP, and HPV vaccines. For instance, culturally tailored education addressing the safety and benefits of HPV vaccination can overcome hesitancy among underserved populations, especially when delivered by trusted community organizations.

By leveraging a comprehensive public health strategy that incorporates bioethics, empathy, and care, this project aims to reduce disparities, promote health equity, and improve overall outcomes for individuals at the intersection of HIV and HPV. Addressing these public health challenges through innovative and ethically grounded interventions ensures a more inclusive approach to healthcare in Alabama’s Black Belt Counties.

Methodological Framework for Educational Interventions

The foundation of an effective process for HPV prevention lies in a robust mixed-methods design that integrates both quantitative and qualitative approaches to gather comprehensive data on intervention outcomes. This design includes pre- and post-intervention surveys to assess changes in participants’ knowledge, attitudes, and behaviors, alongside focus groups that capture in-depth qualitative feedback. Longitudinal tracking over the course of four years enables the evaluation of sustained impacts, providing insights into the long-term efficacy of educational interventions.

The “Protect Me From HPV” app plays a central role in this methodological framework. Designed to facilitate participant engagement, the app allows for streamlined data collection, providing a user-friendly platform for completing surveys, accessing educational resources, and granting informed consent electronically. This digital approach not only enhances efficiency but also improves accessibility for participants who may have limited time or mobility. The app ensures that consent processes are transparent and that participants are fully informed, reinforcing ethical standards.

Tailoring intervention materials to the unique cultural and socioeconomic contexts of Alabama’s Black Belt is essential to foster relevance and engagement. Educational resources are designed with culturally sensitive messaging and localized statistics to resonate with participants’ lived experiences. Incorporating visual aids, relatable examples, and accessible language ensures that the content is understandable and impactful, empowering participants to make informed health decisions.

Evaluation of Process and Outcomes

Evaluating the effectiveness of educational interventions requires a comprehensive approach to measure both immediate and long-term outcomes. Quantitative metrics, such as knowledge gains, vaccination intent, and participation in screening programs, provide clear indicators of success. These are complemented by qualitative data from focus groups and interviews, which offer nuanced insights into participants’ perceptions and experiences.

Regular feedback loops are a critical component of this process, ensuring that the intervention remains responsive to participants’ needs and concerns. Feedback is gathered through periodic surveys and focus group discussions, allowing the research team to refine educational materials and strategies based on participant input. This iterative process not only improves the quality of the intervention but also fosters trust and a sense of ownership among participants, which are key to long-term engagement.

To address the challenges inherent in a multi-year study, strategies are implemented to ensure participant retention and minimize attrition. These include clear communication of the study’s benefits, provision of incentives such as small gift cards, and flexible options for participation through the app or in-person sessions. Oversampling is also employed to account for potential dropouts, ensuring that the study maintains statistical power and robustness.

Addressing Logistical and Operational Challenges

Logistical and operational challenges are inevitable in a project of this scale, particularly in underserved areas like Alabama’s Black Belt. One strategy to mitigate these challenges is deliberate oversampling of participants, which accounts for attrition rates that are typical in long-term studies. By recruiting a larger initial sample, the study ensures that it retains enough participants to draw statistically significant conclusions.

Collaboration with community-based organizations like Five Horizons Health Services (FHHS) is pivotal to the success of the intervention. FHHS provides trusted, established networks within the community, enabling effective outreach and participant recruitment. Additionally, FHHS personnel are trained to administer surveys, conduct workshops, and facilitate the use of the app, ensuring that the intervention is delivered consistently and professionally.

Partnerships with local stakeholders, healthcare providers, and community leaders further enhance the program’s credibility and reach. These partnerships help reduce systemic barriers to care, such as stigma and mistrust, by leveraging the influence and trust these entities hold within the community. Such collaborations also enable the integration of educational efforts with existing healthcare services, creating a more seamless and sustainable model for HPV prevention.

By combining a robust methodological framework, a rigorous evaluation strategy, and proactive logistical planning, this process aims to create a scalable and ethically grounded intervention for HPV prevention. The approach not only addresses immediate health disparities but also lays the groundwork for long-term improvements in public health outcomes across Alabama’s Black Belt.

Black Bioethics: A Justice-Based Approach

Addressing health disparities in Alabama’s Black Belt Counties demands a justice-based approach grounded in Black bioethics. These counties bear the legacy of systemic inequities and historical injustices, including the infamous Tuskegee Syphilis Study, which deeply eroded trust in medical research and healthcare systems within Black communities. Recognizing and confronting this historical context is not just a moral imperative but a necessary step toward rebuilding trust and achieving health equity. Black bioethics prioritizes amplifying the voices of marginalized communities, ensuring their experiences and perspectives guide public health interventions.

The integration of Black bioethics into HPV prevention strategies emphasizes the importance of equitable access to care and the ethical obligation to address structural barriers. By centering the lived realities of Black communities, this approach seeks to dismantle systemic racism and advocate for justice in healthcare delivery. It underscores the moral responsibility of public health initiatives to empower underserved populations through culturally relevant and community-driven strategies. This ethical framework informs every stage of this project, from the design of educational interventions to the evaluation of outcomes, ensuring that HPV prevention efforts are not only scientifically rigorous but also socially just.

Empathy and Care Ethics as Virtues in Public Health Research

The principles of empathy and care ethics are foundational to this project, providing a compassionate and participant-centered lens for public health research. Empathy is essential for fostering relationships and trust with participants, particularly in communities historically marginalized by the healthcare system. By adopting culturally relevant approaches, this project demonstrates a commitment to understanding and addressing the unique needs and concerns of participants in Alabama’s Black Belt Counties.

Care ethics prioritizes the dignity and autonomy of participants at every stage of the project. The informed consent process is designed to ensure that participants fully understand the purpose, risks, and benefits of the study, empowering them to make decisions that align with their values and circumstances. Beyond informed consent, the project emphasizes the importance of aligning interventions with the lived realities of participants. This involves tailoring educational materials to reflect cultural and socioeconomic contexts, thereby enhancing their relevance and effectiveness.

By embedding empathy and care ethics into its methodology, the project not only addresses immediate health disparities but also fosters a deeper sense of trust and collaboration. This participant-centered approach helps overcome barriers to engagement, such as stigma and medical mistrust, while promoting informed health decisions that resonate with the participants’ lived experiences.

Sustaining Ethical Commitments in Research

Ensuring the ethical integrity of this project requires a robust system of ongoing ethical audits and external reviews. These mechanisms serve to uphold ethical standards, identify potential concerns, and adapt practices to align with the evolving needs of participants and the community. By incorporating regular reviews conducted by ethics committees, including community representatives and experts in public health ethics, the project reinforces its commitment to transparency and accountability.

Adaptive processes are another cornerstone of the project’s ethical framework. Participant feedback is continuously integrated into the design and implementation of interventions, ensuring that they remain participant-centered and responsive to community needs. This iterative approach not only enhances the ethical rigor of the project but also strengthens its impact and sustainability.

Long-term partnerships with community-based organizations and local leaders are critical to building trust and ensuring the lasting impact of the project. These partnerships facilitate the co-creation of interventions, empowering communities to take an active role in shaping and sustaining public health initiatives. By establishing these collaborations, the project creates a legacy of trust and shared responsibility, paving the way for future efforts to address health disparities in underserved populations.

Conclusion

This project exemplifies the integration of Black bioethics, care ethics, and empathy as foundational principles for addressing health disparities through HPV prevention. By grounding its methodology in justice and compassion, the project prioritizes the dignity, autonomy, and well-being of participants while dismantling systemic barriers to healthcare access. Through its emphasis on participant-centered approaches, ethical accountability, and long-term community partnerships, the project serves as a model for ethical, community-driven public health research in underserved populations. This framework not only addresses immediate health needs but also fosters trust, equity, and empowerment, ensuring that the benefits of this initiative extend far beyond its conclusion.

Footnotes

Full Disclosure Statement: This paper has utilized artificial intelligence (AI) tools for clarity, grammar refinement, and structural organization to enhance readability and accessibility. The ideas, creativity, and originality presented herein are entirely the intellectual contributions of the authors: Dr. David Augustin Hodge, Sr., Dr. John Heath and Dr. Ehsan Abdalla, and The use of AI was limited to non-substantive editing and formatting tasks, ensuring that the integrity of the scholarly content and the originality of the concepts remain uncompromised.

There are no conflicts of interest to declare in the authorship or publication of this paper. The ethical principles guiding this work prioritize transparency, collaboration, and the dissemination of knowledge for the benefit of underserved communities.

References

  1. Alabama Department of Public Health (ADPH) State of Alabama HIV Surveillance Annual Report. 2019. Retrieved from: https://www.alabamapublichealth.gov/hiv/assets/hivsurveillanceannualreport_2019.pdf.
  2. Alabama Department of Public Health (ADPH) HIV Continuum of Care by Public Health District, Alabama Preliminary 2023. 2023. Retrieved from: https://www.alabamapublichealth.gov/hiv/assets/hivcontinuumcare_2023_preliminary.pdf.
  3. Alabama Department of Public Health (ADPH) Ending the HIV Epidemic (EHE) Retrieved from: https://www.alabamapublichealth.gov/hiv/assets/al-ehe-plan-condensed.pdf.
  4. Boehme AK, Moneyham L, McLeod J, et al. HIV-infected women’s relationships with their healthcare providers in the rural deep south: An exploratory study. Health Care for Women International. 2012;33(5):403–419. doi: 10.1080/07399332.2011.610533. [DOI] [PubMed] [Google Scholar]
  5. British HIV Association. Guidelines on the Use of Vaccines in HIV-Positive Adults. 2015. Retrieved from: http://www.bhiva.org/vaccination-guidelines.aspx.
  6. Centers for Disease Control and Prevention (CDC) HIV Risk Reduction Tool. 2019. Retrieved from: https://hivrisk.cdc.gov/can-prevent-getting-transmitting-hiv/
  7. Centers for Disease Control and Prevention (CDC) NON-OCCUPATIONAL POST-EXPOSURE PROPHYLAXIS (nPEP) IN ADULTS RESOURCE TOOL. Retrieved from: https://escambia.floridahealth.gov/programs-and-services/clinical-health/hiv-aids/_documents/npep-resource-tool-rev-july-2015.pdf.
  8. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. The Lancet. 2007;370(9581):59–67. doi: 10.1016/S0140-6736(07)61050-2. [DOI] [PubMed] [Google Scholar]
  9. Kempf MC, McLeod J, Boehme AK, et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care STDS. 2010;24(8):515–520. doi: 10.1089/apc.2010.0065. [DOI] [PubMed] [Google Scholar]
  10. National Institute of Health (NIH) HIV Prevention: Pre-Exposure Prophylaxis (PrEP) 2023. Retrieved from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/pre-exposure-prophylaxis-prep.
  11. Okunade KS. Human papillomavirus and cervical cancer. Journal of Obstetrics and Gynaecology. 2020;40(5):602–608. doi: 10.1080/01443615.2019.1634030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Palefsky J. Human papillomavirus-related disease in people with HIV. Current Opinion in HIV and AIDS. 2009;4(1):52–56. doi: 10.1097/COH.0b013e32831a7246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ramírez-Fort MK, Khan F, Rady PL, Tyring SK. Current Problems in Dermatology. Vol. 45. Basel, Karger: 2014. Human Papillomavirus: Bench to Bedside; pp. I–VIII. [Google Scholar]
  14. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute. 2015;107(6):djv086. doi: 10.1093/jnci/djv086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sullivan-Blum ZC, Brophy M, Didde R, Nagireddy R, Swagerty H, Weir S, Sykes KJ, Dietz C, Alt M, Ramaswamy M, Rotert P. PrEP patient attitudes, beliefs, and perceived barriers surrounding HPV vaccination: A qualitative study. BMJ Open. 2022;12(4):e058510. doi: 10.1136/bmjopen-2021-058510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tugizov S. Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease. Tissue Barriers. 2016;4(3):e1159276. doi: 10.1080/21688370.2016.1159276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wheldon CW, Sykes KJ, Ramaswamy M, Bass SB, Collins BN, Rotert P. Integrating HPV vaccination within PrEP care delivery for underserved populations: A mixed-methods feasibility study. Journal of Community Health. 2023;48(4):640–651. doi: 10.1007/s10900-023-01202-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Willie TC, Stockman JK, Keene DE, Calabrese SK, Alexander KA, Kershaw TS. Social networks and its impact on women’s awareness, interest, and uptake of HIV pre-exposure prophylaxis (PrEP) JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019;80(4):386–393. doi: 10.1097/QAI.0000000000001935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yuan T, Fitzpatrick T, Ko NY, et al. Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: A systematic review and meta-analysis of global data. The Lancet Global Health. 2019;7(3):e436–e447. doi: 10.1016/S2214-109X(18)30567-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ziemer KL, Smith P, Ray K. Black Bioethics and Cultural Competency in HPV Vaccination Efforts. Journal of Public Health Ethics. 2023;17(2):105–116. [Google Scholar]
  21. Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention: PrEP 101. 2024. Retrieved from: https://lasallecountyil.gov/DocumentCenter/View/801/Pre-Exposure-Prophylaxis-PrEP-101-PDF.
  22. Kamitani E, Johnson WD, Wichser ME, Adegbite AH, Mullins MM, Sipe TA. Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: Systematic review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;84(4):379–386. doi: 10.1097/QAI.0000000000002345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Riddell J, Amico KR, Mayer KH. HIV preexposure prophylaxis: A review. JAMA. 2018;319(12):1261–1268. doi: 10.1001/jama.2018.1917. [DOI] [PubMed] [Google Scholar]
  24. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010;363(27):2587–2599. doi: 10.1056/NEJMoa1011205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Internal Medicine. 2016;176(1):75–84. doi: 10.1001/jamainternmed.2015.4683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical Infectious Diseases. 2015;61(10):1601–1603. doi: 10.1093/cid/civ778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomized trial. The Lancet. 2016;387(10013):53–60. doi: 10.1016/S0140-6736(15)00056-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Farley TM, Samuelson J, Grabowski MK, et al. Impact of male circumcision on risk of HIV infection in men in a changing epidemic context: Systematic review and meta-analysis. Journal of the International AIDS Society. 2020;23:e25490. doi: 10.1002/jia2.25490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sullivan PS, Smith DK, Mera-Giler R, et al. The impact of pre-exposure prophylaxis with TDF/FTC on HIV diagnoses, 2012–2016, United States. Paper presented at: AIDS; Amsterdam, Netherlands. 2018. [Google Scholar]
  30. Department of Public Health, Massachusetts. Post-Exposure Prophylaxis (nPEP) 2024. Retrieved from: https://www.mass.gov/info-details/post-exposure-prophylaxis-npep.
  31. Musinguzi G, Bastiaens H, Matovu JK, et al. Barriers to condom use among high-risk men who have sex with men in Uganda: A qualitative study. PLOS ONE. 2015;10:e0132297. doi: 10.1371/journal.pone.0132297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database of Systematic Reviews. 2002 doi: 10.1002/14651858.CD003255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Johnson WD, O’Leary A, Flores SA. Per-partner condom effectiveness against HIV for men who have sex with men. AIDS. 2018;32(11):1499–1505. doi: 10.1097/QAD.0000000000001848. [DOI] [PubMed] [Google Scholar]
  34. Held V. The Ethics of Care: Personal, Political, and Global. Oxford University Press; 2006. [Google Scholar]
  35. Noddings N. Caring: A Relational Approach to Ethics and Moral Education. 2nd ed. University of California Press; 2013. [Google Scholar]
  36. Slote M. The Ethics of Care and Empathy. Routledge; 2007. [Google Scholar]
  37. Slote M. Moral Sentimentalism. Oxford University Press; 2013. [Google Scholar]
  38. Warren RC, Forrow L, Hodge DA, Sr, Truog RD. Trustworthiness before trust — Covid-19 vaccine trials and the Black community. The New England Journal of Medicine. 2020;383(22):e121. doi: 10.1056/NEJMp2030033. [DOI] [PubMed] [Google Scholar]
  39. Ray K. Black health: The social, political, and cultural determinants of health. American Journal of Bioethics. 2021;21(6):4–6. doi: 10.1080/15265161.2021.1914561. [DOI] [Google Scholar]
  40. Hodge DA. Voices of our fathers: Narrative (care) ethics, trust and trustworthiness. In: Barrett DH, Ortmann LW, Larson SA, editors. Narrative Ethics in Public Health: The Value of Stories. Springer; 2022. [Google Scholar]

Articles from Journal of Healthcare, Science and the Humanities are provided here courtesy of National Center for Bioethics in Health Care, Tuskegee University

RESOURCES